Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@WSJ4 years ago
Pfizer and BioNTech began the formal process of seeking FDA clearance for a Covid-19 booster shot, submitting data showing a third vaccine dose generated higher levels of neutralizing antibodies against the original virus and its Beta and Delta variants on.wsj.com
